Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0LZ4V
|
|||
| Drug Name |
PMID27551786-Compound-II
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
Merck Sharp & Dohme
|
|||
| Structure |
 |
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Mineralocorticoid receptor (MR) | Target Info | Antagonist | [1] |
| Target's Patent Info | Mineralocorticoid receptor (MR) | Target's Patent Info | [1] | |
| KEGG Pathway | Aldosterone-regulated sodium reabsorption | |||
| Pathwhiz Pathway | Kidney Function | |||
| WikiPathways | ACE Inhibitor Pathway | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Mineralocorticoid receptor antagonists: a patent evaluation of US20150284376A1.Expert Opin Ther Pat. 2016 Sep 14:1-4. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.